Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study

BMC Pulm Med. 2015 Nov 7:15:141. doi: 10.1186/s12890-015-0133-9.

Abstract

Background: Bronchiectasis is characterized by abnormal, permanent and irreversible dilatation of the bronchi, usually responsible for daily symptoms and frequent respiratory complications. Many causes have been identified, but only limited data are available concerning the association between bronchiectasis and renal transplantation.

Methods: We conducted a retrospective multicenter study of cases of bronchiectasis diagnosed after renal transplantation in 14 renal transplantation departments (French SPIESSER group). Demographic, clinical, laboratory and CT scan data were collected.

Results: Forty-six patients were included (mean age 58.2 years, 52.2 % men). Autosomal dominant polycystic kidney disease (32.6 %) was the main underlying renal disease. Chronic cough and sputum (50.0 %) were the major symptoms leading to chest CT scan. Mean duration of symptoms before diagnosis was 1.5 years [0-12.1 years]. Microorganisms were identified in 22 patients, predominantly Haemophilus influenzae. Hypogammaglobulinemia was observed in 46.9 % patients. Bronchiectasis was usually extensive (84.8 %). The total bronchiectasis score was 7.4 ± 5.5 with a significant gradient from apex to bases. Many patients remained symptomatic (43.5 %) and/or presented recurrent respiratory tract infections (37.0 %) during follow-up. Six deaths (13 %) occurred during follow-up, but none were attributable to bronchiectasis.

Conclusions: These results highlight that the diagnosis of bronchiectasis should be considered in patients with de novo respiratory symptoms after renal transplantation. Further studies are needed to more clearly understand the mechanisms underlying bronchiectasis in this setting.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Agammaglobulinemia / epidemiology*
  • Aged
  • Aged, 80 and over
  • Azathioprine / therapeutic use
  • Bronchiectasis / complications
  • Bronchiectasis / diagnostic imaging
  • Bronchiectasis / epidemiology*
  • Bronchiectasis / physiopathology
  • Chronic Disease
  • Cough / etiology
  • Cyclosporine / therapeutic use
  • Everolimus / therapeutic use
  • Female
  • Forced Expiratory Volume
  • Graft Rejection / prevention & control*
  • Haemophilus Infections / epidemiology*
  • Haemophilus influenzae
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / statistics & numerical data*
  • Male
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Polycystic Kidney, Autosomal Dominant / complications
  • Polycystic Kidney, Autosomal Dominant / surgery
  • Respiratory Tract Infections / epidemiology*
  • Retrospective Studies
  • Risk Factors
  • Rituximab / therapeutic use
  • Sirolimus / therapeutic use
  • Tacrolimus / therapeutic use
  • Tomography, X-Ray Computed
  • Vital Capacity
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Rituximab
  • Cyclosporine
  • Everolimus
  • Mycophenolic Acid
  • Azathioprine
  • Sirolimus
  • Tacrolimus